Dodgers Land Skubal; Two-Time Cy Young Ace Arrives in Pennant Push

By Justin Erickson ·

Los Angeles trades prospect capital for the AL's most dominant starter in a mid-season deadline move that reshapes the National League rotation picture.

Dodgers Land Skubal; Two-Time Cy Young Ace Arrives in Pennant Push

The Dodgers have acquired two-time AL Cy Young winner Tarik Skubal from the Tigers in a blockbuster trade, per MLB.com's Mark Feinsand. Los Angeles is sending outfield prospect Zyhir Hope (the club's No. 5 prospect, MLB's No. 25), right-hander River Ryan (No. 7, MLB No. 68), and right-hander Brady Smith (No. 17) to Detroit. The move arrives just weeks before the August 2 trade deadline and marks the most significant pitching acquisition on the market—a clear signal that the Dodgers view themselves as pennant contenders despite the competitive NL West.

Skubal's path to Los Angeles was complicated by injury. A loose body in his left elbow forced arthroscopic surgery in early June, a procedure that would typically sideline a pitcher six to eight weeks. The Tigers deployed a Nanoscope technique—a minimally invasive arthroscopic tool that reduced surrounding muscle damage—allowing Skubal to return in mid-June rather than late July. His first few starts showed rust, but by late July his mechanics and velocity had stabilized. On July 24, just eight days ago, he punched out 12 strikeouts over 7⅓ innings against Kansas City. His fastball is holding at upper-90s velocity, his changeup remains elite, and the recent performance data suggests the injury is behind him.

The Tigers' calculus was straightforward: Skubal will test free agency after this season as the top available pitcher on the market. Detroit's struggles through the first two months (Skubal's injury coinciding with rotation weakness) created a window where contenders began circling. Rather than risk losing him to free agency for nothing, the Tigers extracted significant prospect value. The deal underscores a macro reality—Skubal was never staying in Detroit long-term, and the team's front office chose to cash in mid-season rather than ride out a final losing year.

For bettors, Skubal's arrival changes Dodgers rotation leverage for playoff-critical matchups. He enters a lineup that has Freddie Freeman, Mookie Betts, and Shohei Ohtani, creating a high-leverage offensive environment that will suppress run-scoring in his starts. Over his last six starts (since mid-June recovery), Skubal's strikeout rate has stabilized at 11.2 per nine innings despite the early-season noise. The Dodgers' offense averages 4.8 runs per game; pair that with a two-time Cy Young arm and you have a pitcher whose game lines will lean toward lower team totals and higher strikeout props in his debut starts. Early Dodgers team totals when Skubal pitches should compress relative to their season baseline.

The injury recovery timeline and recent performance data suggest no lingering mechanical concerns—the Nanoscope procedure's minimal tissue damage likely means Skubal avoids the typical setbacks that often shadow elbow surgery. This is a durable ace arriving in mid-season form, not a question mark. Expect the market to price his strikeout props aggressively (the two Cy Young awards create name-value inflation), but his matchups against weaker AL offenses in late August and September may offer value if books lean on recent results rather than context.